1. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S);Pyorala;Diabetes Care,1997
2. Abbott RD, McGee D. The probability of developing certain cardiovascular disease in eight years at specified values of some characteristics. In: Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Washington, D.C.: U.S. Department of Health, Education, and Welfare; 1987:1-242. Publication NIH 87-2284
3. Cupples LA, D’Agostino RB, Kiely D. Survival following initial cardiovascular events: 30 year follow-up. In: Kannel WB, Wolf PA, Garrison RJ, eds. The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Bethesda, Maryland: National Heart, Lung and Blood Institute; 1988:1-453. Publication NIH 88-2969
4. Estimating the benefits of modifying risk factors of cardiovascular disease. A comparison of primary vs secondary prevention;Grover;Arch Intern Med,1998
5. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction;Haffner;N Engl J Med,1998